Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Chemmedchem|February 1, 2021
E7766, a Macrocycle-Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan-Genotypic ActivityDae-Shik Kim, Atsushi Endo, Francis G Fang, et al.
Cancer Biology & Therapy|March 3, 2015
Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network traffickingXingfeng Bao, Wanjun Zheng, Naoko Hata Sugi, et al.
The Oncologist|October 1, 2022
A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 StudyYusuke Chihara, Takayuki Takeda, Yasuhiro Goto, et al.
Cancer Treatment and Research Communications|July 4, 2024
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancerKanako Sakaeda, Koji Kurose, Yuki Matsumura, et al.
Thoracic Cancer|September 7, 2023
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO studyHiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda, et al.
Advances in Clinical Chemistry|January 15, 2023
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markersKoji Kurose, Kanako Sakaeda, Minoru Fukuda, et al.
Thoracic Cancer|July 9, 2022
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST studyKazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda, et al.
British Journal of Cancer|September 14, 2020
Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumoursMotohiro Nonaka, Misa Suzuki-Anekoji, Jun Nakayama, et al.
Cell|April 24, 2024
IGSF8 is an innate immune checkpoint and cancer immunotherapy targetYulong Li, Xiangyang Wu, Caibin Sheng, et al.
Cancer Medicine|May 13, 2021
The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatmentNaoko Sueoka-Aragane, Chiho Nakashima, Hironori Yoshida, et al.
Pageof 27